Document is current
Any future updates will be listed below
-
Authors
Gómez-Peralta, F http://orcid.org/0000-0003-0106-0091
Menéndez, E http://orcid.org/0000-0002-9548-7821
Conde, S
Conget, I http://orcid.org/0000-0002-5532-5449
Novials, A http://orcid.org/0000-0003-0465-2949
,
Serrano Olmedo, Isabel
Tinahones, Francisco
Carral San Laureano, Florentino
López de la Torre, Martín
Moreno Carazo, Alberto
Acha, Javier
Bandrés, Orosia
Masmiquel, Lluís
Payeras, Francisca
Gómez, Ignacio Llorente
Bayo, Juan Angel Hernández
Montalbán, Coral
de Luis, Daniel
Díaz-Soto, Gonzalo
López-Guzmán, Antonio
Santos-Mazo, Estefania
López Jiménez, Luz Mª
Alvarez, Visitacion
Blanco Samper, Benito
Chico, Ana
Dalama, Belen
Pérez-Maraver, Manuel
Soldevila, Berta
Capel Flores, Ismael
Hernández García, Marta
Ricart, Wifredo
Megia Colet, Ana
Climent Biescas, Elisenda
Ampudia-Blasco, Francisco Javier
Hernández-Mijares, Antonio
Sánchez-Juan, Carlos
Picó, Antonio
Domínguez Escribano, José Ramón
Fajardo, Carmiña
Pedro, Teresa
Abellán, Pablo
Rossetti, Paolo
Morales-Pérez, Francisco M.
Enciso, Fidel
Soto González, Alfonso
Bellido, Diego
Luna Cano, Reyes
García López, José Manuel
Andía, Víctor Manuel
Arranz Martín, José Alfonso
Azriel, Sharona
Botella Serrano, Marta
Brito Sanfiel, Miguel
Calle Pascual, Alfonso
del Cañizo Gómez, Francisco Javier
Gargallo Fernández, Manuel Ángel
Illán, Fátima
Hernández Martínez, Antonio M.
Forga Llenas, Lluis
Gaztambide, Sonia
Fuentes Gómez, Clara Rosario
Oleaga, Amelia
Martínez de Salinas, Mª Ángeles
López-Siguero, Juan Pedro
Gómez-Gila, Ana Lucía
Lechuga Sancho, Alfonso María
Ferrer Lozano, Marta
Riaño Galán, Isolina
Caimari, María
Cardona, Roque
Clemente León, María
Carreras González, Gemma
Diez, Francisco Javier Arroyo
Rodríguez, Paloma Cabanas
Roldán, Belén
González Pérez del Villar, Noemí
Ros Pérez, Purificación
Rica, Itxaso
Diez López, Ignacio
- License Information
-
More Information
Article History
Received: 16 November 2022
Accepted: 3 July 2023
First Online: 26 July 2023
Declarations
:
: This study was performed in accordance with the principles stated in the Declaration of Helsinki and approval was granted for the study by the <i>Comité de Ética de La Investigación con Medicamentos del Área De Salud De Segovia</i> (Ethics Committee (EC), General Hospital Segovia, Segovia, Spain) and the ECs of all the participant hospitals. All participants were aware of the research and volunteered to participate and confidentiality were assured. We obtained written informed consent from all participants. Informed consent from a parent and/or legal guardian for study participation were obtained in case of illiterate participants.
: Not applicable.
: Fernando Gómez-Peralta has participated in Expert Panels for Abbott Diabetes, Novartis, Astra Zeneca, Sanofi and Novo Nordisk; participated as principal investigator in Clinical Trials funded by Sanofi, Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, and Lilly; and has participated as a speaker for Abbott Diabetes, Novartis, Sanofi, Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co., and Lilly.Edelmiro Luis Menéndez Torre has participated as an investigator in clinical trials funded by Sanofi and Novo Nordisk, has participated as a speaker for Abbott Diabetes, Sanofi, Novo Nordisk, AstraZeneca, Menarini and Lilly; and has received funding for education and research from Sanofi, Roche and Medtronic.Santiago Conde Barreiro has participated as a consultant for Sanofi, has participated as a speaker for Lilly and Roche, has received funding to participate in congress courses from Abbott Diabetes, Ascensia, Sanofi, Lilly and Novo Nordisk.Ignacio Conget has received funding as a consultant and speaker for Medtronic, Bayer, Ascensia, GlaxoSmithKline, Eli Lilly, Novo Nordisk, Sanofi-Aventis, Novartis and MSD.Anna Novials declares that she has no conflict of interest.
